INS and type 1 diabetes mellitus: In both autoimmune patients and murine models of autoimmunity, DCs exhibit alterations in phenotype or function that could be due to underlying genetic defects or the chronic inflammatory environment, and can affect both the initiation of disease and later failure of tolerance mechanisms that lead to tissue destruction such as loss of insulin-producing beta cells in T1D (Figure 1).